免疫调节剂用于免疫检查点抑制剂治疗后的类固醇依赖性复发性急性胰腺炎:一系列病例
Hannah Peck1, Wilfredo Pagani2, Arianna Smith3
1Medical College of Wisconsin, Milwaukee, WI.
ACG case reports journal
|April 4, 2025
概括
免疫检查点抑制剂诱导的胰腺炎 (ICI-IP) 可以复发. 像mycophenolate mofetil和azathioprine这样的免疫调节剂在两名患者中有效地管理了复发性ICI-IP,防止了进一步的发作.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
背景情况:
- 免疫检查点抑制剂 (ICI) 是关键的癌症疗法.
- 在ICI治疗的患者中,有1-2%患上ICI诱导的胰腺炎 (ICI-IP).
- 即使在ICI停止后,也可能发生反复的ICI-IP.
研究的目的:
- 为了呈现一种复发性类固醇反应性ICI-IP的案例系列.
- 评估免疫调节剂作为类固醇节约剂的疗效,用于复发性ICI-IP.
- 为了突出mycophenolate mofetil和azathioprine用于管理耐火性ICI-IP.
主要方法:
- 两名患有复发性ICI-IP的患者的病例系列.
- 使用免疫调节剂 (mycophenolate mofetil和azathioprine) 作为类固醇节约疗法进行治疗.
- 长期跟踪评估复发和并发症.
主要成果:
- 这两位患者都实现了胰腺炎的持续缓解.
- 免疫调节剂治疗持续了大约两年.
- 治疗后没有观察到胰腺炎的进一步复发或并发症.
结论:
- 复发性ICI-IP可以通过免疫调节剂有效管理.
- 菌酸莫菲提尔和阿扎西奥普林是复发性ICI-IP的可行的类固醇节约选择.
- 这种方法为耐火性ICI诱导胰腺炎患者提供了一个有前途的策略.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
109
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
109
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
91
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
91
01:29Chronic Pancreatitis II: Collaborative Care
50
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
50
01:27Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
01:29Inflammatory Bowel Disease IV: Pharmacological Management
82
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
82
01:30Acute Pancreatitis II: Clinical Manifestations and Management
75
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
75